BACKGROUND: According to the current guidelines for acute myocardial infarction, ventricular fibrillation during the acute phase of myocardial infarction is no indication for specific treatment like ICD implantation. Primary objective of our study was to evaluate the prognostic significance of cardiac arrest within the acute phase of myocardial infarction in patients with moderately reduced left ventricular function. METHODS AND RESULTS: From 1994 until 2004, we included 7111 patients with acute STEMI and an LVEF >30% from the MITRA plus registry who were discharged alive from hospital and had a complete follow up. We compared long term prognosis on total mortality in patients with and without prehospital cardiac arrest. 286 out of 7111 patients (4%) with moderately reduced LVEF >30% after STEMI had prehospital cardiac arrest and were discharged alive from hospital. In these patients, total mortality during a mean follow up of 13 months was 13.6% compared to 8.7% in patients without cardiac arrest, although patients with cardiac arrest were younger and had less risk factors. Higher mortality after cardiac arrest was independent from gender, risk factors and medical treatment. Only in patients with preserved LVEF >55% after STEMI, mortality was equal in patients with and without cardiac arrest. CONCLUSION: Prehospital cardiac arrest in the acute phase of STEMI is an independent risk indicator for higher mortality in patients with moderately reduced left ventricular function (LVEF 30-55%). To evaluate the prognostic impact of the implantation of an ICD in these patients, further investigation is needed.
BACKGROUND: According to the current guidelines for acute myocardial infarction, ventricular fibrillation during the acute phase of myocardial infarction is no indication for specific treatment like ICD implantation. Primary objective of our study was to evaluate the prognostic significance of cardiac arrest within the acute phase of myocardial infarction in patients with moderately reduced left ventricular function. METHODS AND RESULTS: From 1994 until 2004, we included 7111 patients with acute STEMI and an LVEF >30% from the MITRA plus registry who were discharged alive from hospital and had a complete follow up. We compared long term prognosis on total mortality in patients with and without prehospital cardiac arrest. 286 out of 7111 patients (4%) with moderately reduced LVEF >30% after STEMI had prehospital cardiac arrest and were discharged alive from hospital. In these patients, total mortality during a mean follow up of 13 months was 13.6% compared to 8.7% in patients without cardiac arrest, although patients with cardiac arrest were younger and had less risk factors. Higher mortality after cardiac arrest was independent from gender, risk factors and medical treatment. Only in patients with preserved LVEF >55% after STEMI, mortality was equal in patients with and without cardiac arrest. CONCLUSION: Prehospital cardiac arrest in the acute phase of STEMI is an independent risk indicator for higher mortality in patients with moderately reduced left ventricular function (LVEF 30-55%). To evaluate the prognostic impact of the implantation of an ICD in these patients, further investigation is needed.
Authors: Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel Journal: Europace Date: 2006-08-25 Impact factor: 5.214
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: J Rustige; R Schiele; U Burczyk; A Koch; M Gottwik; K L Neuhaus; U Tebbe; R Uebis; J Senges Journal: Eur Heart J Date: 1997-09 Impact factor: 29.983
Authors: Manuel Ruiz-Bailén; Eduardo Aguayo de Hoyos; Silvia Ruiz-Navarro; Ziad Issa-Khozouz; Antonio Reina-Toral; Miguel Angel Díaz-Castellanos; Juan-José Rodríguez-García; Juan Miguel Torres-Ruiz; Antonio Cárdenas-Cruz; Angel Camacho-Víctor Journal: Crit Care Med Date: 2003-08 Impact factor: 7.598
Authors: C Dubois; J P Smeets; J C Demoulin; L Piérard; G Foidart; L Henrard; C Tulippe; L Preston; J Carlier; H E Kulbertus Journal: Eur Heart J Date: 1986-11 Impact factor: 29.983
Authors: Jeffrey S Healey; Al P Hallstrom; Karl-Heinz Kuck; Girish Nair; Eleanor P Schron; Robin S Roberts; Carlos A Morillo; Stuart J Connolly Journal: Eur Heart J Date: 2007-02-05 Impact factor: 29.983
Authors: H Löwel; A Dobson; U Keil; B Herman; M S Hobbs; A Stewart; M Arstila; H Miettinen; H Mustaniemi; J Tuomilehto Journal: Circulation Date: 1993-12 Impact factor: 29.690
Authors: Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier Journal: Clin Res Cardiol Date: 2010-02-04 Impact factor: 5.460
Authors: Christopher W Seymour; Roger A Band; Colin R Cooke; Mark E Mikkelsen; Julie Hylton; Tom D Rea; Christopher H Goss; David F Gaieski Journal: J Crit Care Date: 2010-04-08 Impact factor: 3.425
Authors: Christoph Liebetrau; Sebastian Szardien; Johannes Rixe; Mariella Woelken; Andreas Rolf; Timm Bauer; Holger Nef; Helge Möllmann; Christian Hamm; Michael Weber Journal: Clin Res Cardiol Date: 2010-09-21 Impact factor: 5.460
Authors: Ralf Koester; Jan Kaehler; Achim Barmeyer; Kai Müllerleile; Marion Priefler; Gerold Soeffker; Stephan Braune; Axel Nierhaus; Thomas Meinertz; Stefan Kluge Journal: Clin Res Cardiol Date: 2011-06-21 Impact factor: 5.460